Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Noteable

T.ONC

RE:RE:Pelareorep in 3rd line HR+/HER2 negative breast cancer

Oct. 1, 2024 Rates of breast cancer — the second leading cause of cancer...

October 11, 2024

T.ONC

RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals

October 11. 2024 -   Clayton Dubilier & Rice is nearing a...

October 11, 2024

T.ONC

RE:Pelareorep in 3rd line HR+/HER2 negative breast cancer

October 11, 2024 - Roche's drug, inavolisib, has gained FDA approval ...

October 11, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024

Correction that should read: Another factoid is that allogenic CAR-T...

October 9, 2024

T.ONC

RE:RE:RE:BNN

ONCY Time stamp: 02:15  https://www.bnnbloomberg.ca/video/shows/the...

October 7, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024

Reformatted information: In 2022, there were 2.3 million women diagnosed...

October 7, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024

  Stockhouse Logo Search Companies, etc     Quote...

October 7, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:Pelareorep in 3rd line HR+/HER2 negative breast cancer

As reminder regarding the acquisition of an early stage Phase 1 single agent...

October 4, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

What Bracelet-1 has demonstrated was that pelareorep is effective as a single...

October 4, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

Bracelet-1 demonstrated 2 major findings: (1) PD-L1 with an activated Fc...

October 4, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

Should read : ONCY's BRACELET-1 Phase 2 mBC has demonstrated pelareorep...

October 4, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

For those who don't understand these distinctions and differences, ONCY...

October 4, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

The synergy of pelareorep + checkpoint inhibitors is with CPIs that have an...

October 4, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

It's remarkable how those like Quentin30, who doesn't own any shares...

October 4, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:Pelareorep in 3rd line HR+/HER2 negative breast cancer

 Roche/Genentech announced an US$850 Million up-front cash payment&...

October 2, 2024

T.ONC

RE:G12D/G12V KRAS mutation in PC & CRC patients respond to Pela

October 02, 2024 - The clinical ranks for the development of a KRAS G12D...

October 2, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:Pelareorep in 3rd line HR+/HER2 negative breast cancer

Pfizer continues to advance its aim of developing next generation therapies...

October 2, 2024

T.ONC

RE:RE:RE:RE:RE:RE:Pelareorep in 3rd line HR+/HER2 negative breast cancer

September 30, 2024 - Roche/Genentech announced an US$850 Million up...

October 2, 2024

T.ONC

RE:RE:RE:RE:Moderna's CEO Stephan Bancel comments on mRNA cancer vaccine

September 12, 2024 - Last month Moderna was hoping for a quick green light...

October 2, 2024

T.ONC

RE:RE:RE:Regarding information being kept

ONCY's reference to US$ 2.4 Billion only pertains to their projected 5th...

October 2, 2024

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Anfield Energy Inc

Anfield Energy Inc V.AEC

Anfield Energy Inc. is a Canada-based uranium and vanadium development and near-term production company. A key asset in the ... view more »